What We Do

SMT’s products address critical, unmet needs in the health care industry: improved information management, specimen processing, blood product development, quality assurance and control, data confidentiality and security, and cost containment. SMT is committed to ensuring that all products comply with applicable regulatory standards and guidelines including those mandated by the FDA for product development and commercialization. The core markets that we target include clinical and research laboratories, hospitals, blood banks, blood product companies, and clinical trials management. The company estimates that the markets we target exceed $2 billion and are growing at a rate of 15%.

Home    Back To Top